Proactiveinvestors United Kingdom - Health Care, Equipment & Services RSS feed Proactiveinvestors United Kingdom - Health Care, Equipment & Services feed en Thu, 22 Feb 2018 19:07:58 +0000 Genera CMS National Milk Records ups growth ante with added value tech Thu, 22 Feb 2018 11:21:00 +0000 Concepta launches myLotus app in China Tue, 20 Feb 2018 07:20:00 +0000 WideCells Group launches Wideacademy platform and appoints new non-executive director Mon, 19 Feb 2018 08:12:00 +0000 Indivior increases provisions for litigation matters, but 2017 revenue, profit both rise Thu, 15 Feb 2018 11:08:00 +0000 Concepta signs marketing deal with Chinese firm which provides free WiFi in maternity hospitals Thu, 15 Feb 2018 08:15:00 +0000 ConvaTec 2017 profits fall on supply issues and lower sales of new products Thu, 15 Feb 2018 08:13:00 +0000 National Milk Records boosted by dairy price recovery Tue, 13 Feb 2018 09:20:00 +0000 Indivior files another lawsuit in latest bid to stop copycats of its best-selling addiction drug Thu, 08 Feb 2018 09:15:00 +0000 ConvaTec heads higher as City broker upgrades to ‘hold’ ahead of new year Wed, 07 Feb 2018 10:34:00 +0000 Akers Biosciences funded to profitability as it gears up for transformational year Wed, 31 Jan 2018 12:32:00 +0000 Concepta shares “invaluable” data from Chinese hospital tests of fertility product Mon, 29 Jan 2018 13:39:00 +0000 Physiomics lands pre-clinical contract for virtual tumour tech Fri, 26 Jan 2018 08:16:00 +0000 McCarthy & Stone puts plan in place to offset impact of crackdown on ground rents Wed, 24 Jan 2018 08:46:00 +0000 OptiBiotix Health sweetener performs well in independent taste test Tue, 23 Jan 2018 15:55:00 +0000 OptiBiotix to showcase industry-leading technology at top conference next month Wed, 17 Jan 2018 08:21:00 +0000 Indivior inks deal worth US$330mln as it searches for the next generation addiction treatment Wed, 03 Jan 2018 07:55:00 +0000 FTSE 100 stocks you should have bet your house on in 2017 Sat, 30 Dec 2017 08:00:00 +0000 Advanced Oncotherapy says development of LIGHT system on track Thu, 28 Dec 2017 13:05:00 +0000 Concepta addresses supply chain issues after order delay of myLotus fertility product Fri, 22 Dec 2017 11:54:00 +0000 McCarthy & Stone calls for exemption to government's plan to cut ground rents Thu, 21 Dec 2017 09:22:00 +0000 WideCells strengthens management and advisory team as it embarks on a “new period of growth” Thu, 21 Dec 2017 08:29:00 +0000 Akers Biosciences unveils plans to raise US$6mln Tue, 19 Dec 2017 07:52:00 +0000 C4X Discovery expects “significant progress” in 2018 as it looks for a partner to take its addiction drug through the clinic Thu, 14 Dec 2017 10:22:00 +0000 Concepta says myLotus fertility product got an “excellent reception” at meeting of potential distributors in China Thu, 14 Dec 2017 10:12:00 +0000 OptiBiotix inks US manufacturing and supply deal for its SlimBiome appetite suppressant Tue, 12 Dec 2017 11:19:00 +0000 FDA accepts Indivior’s new drug application for schizophrenia treatment Tue, 12 Dec 2017 09:54:00 +0000 Akers Biosciences says its Health and Wellness product line now protected by ten patents Fri, 08 Dec 2017 15:43:00 +0000 Lower blood pressure guidance will highlight Optibiotix's cholesterol reducer believes chief Thu, 07 Dec 2017 14:28:00 +0000 Advanced Oncotherapy secures £37.4mln of new financing Thu, 07 Dec 2017 12:11:00 +0000 OptiBiotix names food industry heavy hitter as its new chairman Tue, 05 Dec 2017 11:07:00 +0000 Concepta PLC launches myLotus app for Android in China Erik Henau, chief executive of Concepta PLC (LON:CPT), discusses with Proactive the launch in China of the myLotus app.

The app accompanies their myLotus fertility aid.

Beijing Jiayou (AppInChina) will manage the app on Android systems throughout the country.

Through AppInChina, Concepta will market the app through the top 5 Chinese Android app stores.

Tue, 20 Feb 2018 11:56:00 +0000
WideCells Group strengthens board; launches Wideacademy Joao Andrade, chief executive of WideCells Group PLC (LON:WDC) as well as chairman Peter Presland discuss with Proactive's Andrew Scott the official launch of the first stage of Wideacademy -
the firm’s 100%-owned education and training division.

The newly launched platform provides content for both the public and medical professionals to raise the profile of stem cell technologies and support the development of the industry.

Mon, 19 Feb 2018 16:00:00 +0000
National Milk Records' Andy Warne discusses operations and significant growth prospects Andy Warne, managing director of National Milk Records (NEX:NMR), tells Proactive they're a service provider in the diary industry.

''The basic services we provide are for farmers to become more efficient'', Warne says

''So it's the quality of the food they're producing and the volume of foo they're producing .... so our primary client is the dairy farmer but we also have a second business where we actually test milk on behalf of the milk processor''.

Profits in the half year to December more than doubled to £957,000 as conditions eased for the sector.

Wed, 14 Feb 2018 12:50:00 +0000
OptiBiotix Health 'in the strongest position they've ever been' Stephen O'Hara, chief executive of OptiBiotix Health plc (LON:OPTI) tells Proactive's Andrew Scott the big focus for them now is on the commercialisation of their technology across the company's platforms.

''2018 has started off very, very well'', O'Hara says.

He mentions they'll be presenting next week at ProBiota in Barcelona - a leading conference attended by the movers and shakers of the industry.

The poster and verbal exposition will focus on OptiBiotix's ability to identify and develop targeted prebiotics which can enhance the growth rate and health benefits of specific microbial species. In doing so they aid the efficacy of probiotic products.

''We've got a lot going on and a lot of relationships with partners that we haven't announced but are close to formalising deals on''.

Thu, 01 Feb 2018 12:56:00 +0000
WideCells strengthens management and advisory team CEO and Founder of WideCells Group (LON:WDC)  Joao Andrade tells Proactive how after recent product development/launches it's now time for the company to push through significant new appointments to make way for increased revenues during 2018.
WideCells is a worldwide healthcare services company focused on collecting and storing stem cells and providing ground breaking insurance for stem cell treatment.
Joao explains how WideCells also has plans now to look at the next stage in developing their insurance products and well as giving updates on their significant new team-up with WG Partners.

Thu, 21 Dec 2017 10:42:00 +0000
Optibiotix Health eyes up future projects Per Rehne of Optibiotix Health (LON:OPTI) tells Proactive how the company's commercial journey through clinical trails, manufacturing and ultimately selling is a careful process of which he's been perfecting since he joined nine months ago. OptiBiotix was formed in March 2012 to develop compounds which modify the human microbiome - the collective genome of the microbes in the body - to prevent and manage human disease. Expanding the worldwide Optibiotix project portfolio is now the focus...hear how Per and the team intend to do just that.

Wed, 20 Dec 2017 08:40:00 +0000
Advanced Oncotherapy maps out plans for growth following £30mln deal with Yantai CIPU Nicolas Serandour, chief executive of Advanced Oncotherapy PLC (LON:AVO), visited the Proactive Investors studio to add some extra detail to their recent announcement that they've secured £37.4mln of fresh funding - £30mln of this coming from a new Chinese investor.

The injection will bankroll the continuing technical development of the firm’s first LIGHT system and its installation at the Harley Street Proton Therapy Centre.

Wed, 13 Dec 2017 08:18:00 +0000
Cheers for the new Chairman at Optibiotix Optibiotix Health (LON:OPTI) CEO Stephen O'Hara tells Proactive why Former Express Dairies and Arla Foods Chief Executive Neil Davidson is the man to take the life sciences group forward into 2018/19. It means the new boardroom hire brings with him significant FTSE 100 experience and a personal interest in the development and commercialisation of technology to improve health.

Tue, 05 Dec 2017 15:55:00 +0000
Small cap spotlight: Advanced Onco, Midwich Group and Prairie Mining Small cap expert Alan Green casts his eye over Advacned Oncotherapy PLC (LON:AVO), Prairie Mining Ltd (LON:PDZ) and Midwich Group Plc (LON:MIDW).

Fri, 17 Nov 2017 13:00:00 +0000
C4X Discovery preparing to do something 'very different' in drug development Clive Dix, chief executive of C4X Discovery Holdings plc, (LON:C4XD) brings Proactive up to speed on developments with the firm's portfolio of drug candidates.

They've recently presented some pre-clinical data at a leading industry conference which they say strengthens the evidence base backing the potential of the anti-addiction drug Orexin-1.

It's being developed to target the craving process and therefore is expected to be used across a broad range of substance disorders.

The latest study assessed nicotine self-administration and cue-induced reinstatement; the latter is where strong cravings are triggered by an object or ritual closely associated with taking an addictive substance.

Tue, 14 Nov 2017 15:19:00 +0000
Concepta raises £2mln to fund China expansion Erik Henau, chief executive of Concepta plc (LON:CPT), tells Proactive they've conditionally raised £2mln in an over-subscribed share placing as well as received formal sign-off today on a £600,000 Chinese deal.

The proceeds of the raise will be used to fund the fertility specialist's expansion in the People’s Republic, though some of the cash will be invested in new product development.

Mon, 13 Nov 2017 15:44:00 +0000
Massive opportunities for OptiBiotix Health's new and improved SlimBiome Christina Wood, Sales & Marketing Director for OptiBiotix Health plc (LON:OPTI) and Max Tomlinson, founder and creator of GoFigure, update Proactive's Andrew Scott on the commercial progress being made with SlimBiome.

Slimbiome is their patented combination of natural ingredients which supports scientifically substantiated weight loss claims.

OptiBiotix has recently signed a profit sharing agreement with Knighton Foods, which will manufacture and distribute SlimBiome.

Mon, 06 Nov 2017 12:52:00 +0000
AIM winner sees big European opportunities after Ecuphar deal Christiaan Cardon, chief executive of Animalcare Group PLC (LON:ANCR) tells Proactive they're a growing business - developing, selling and marketing veterinary pharmaceuticals to niche markets.

Cardon says they want to become one of the leaders in Europe.

This year the group won the AIM Transaction of the Year Award following the acquisition of Ecuphar NV, a European animal health company that develops and sells veterinary pharmaceutical products.

Fri, 27 Oct 2017 15:28:00 +0100
Optibiotix Health focused on marketing and ramping up revenues Proactive Investors sits down with Per Rehne, commercial director of OptiBiotix Health plc (LON:OPTI).

The human microbiome specialist's recently agreed for its cholesterol and blood pressure reducing LP-LDL strain to be sold in Spain, Chile, Peru and the Middle East in a three-year deal with Galenicum Special Ingredients.

The non-exclusive deal will see LP-LDL added to Galenicum's STOP&GO range of capsules, which are sold under the brand Cardiocare.

Fri, 27 Oct 2017 14:38:00 +0100
Concepta secures two additional myLotus distribution agreements in China Erik Henau, chief executive of Concepta plc (LON:CPT), tells Proactive they've signed an additional two 3-year exclusive distribution agreements for their myLotus fertility product.

The agreement with Huanzhong Biotech will cover the province of Hebei near Beijing, while Wanma Technology covers Shanghai.

Mon, 16 Oct 2017 15:06:00 +0100
WideCells takes CellPlan to Spain João Andrade, chief executive of WideCells Group PLC (LON:WDC), tells Proactive they're to launch their stem cell healthcare insurance plan in Spain following the product’s debut in the UK and alongside the imminent roll-out in Brazil.

The local agent for the CellPlan, which costs £170 a year, will be a company called Stem Cell Banco Celulas Madre, a provider of stem cell storage services.

Under the re-seller model, the tie-up should generate £50 per sale (after commissions and reinsurance costs)

Thu, 12 Oct 2017 08:25:00 +0100
Widecells makes move into North Africa, Middle East and Asia-Pacific Joao Andrade, chief executive of Widecells Group PLC (LON:WDC), tells Proactive they're in the process of inking a deal worth an initial £255,000 that will take the group's stem cell services into the Middle East, North Africa and Asia-Pacific regions.

Andrade says they're aiming to have a formal agreement with Gulf-based White Apex General Trading in place by the end of the month.

Wed, 11 Oct 2017 11:18:00 +0100
WideCells opens up its Manchester HQ and laboratory to Proactive Investors WideCells Group PLC (LON:WDC) chief executive Joao Andrade and chief scientific officer Dr Peter Hollands give Proactive a tour of their headquarters and laboratory at the University of Manchester Innovation Centre.

Dr Hollands also gives us an exclusive look at their Cryogenics section - where they store stem cells for future use.

Tue, 03 Oct 2017 09:46:00 +0100
WideCells combining education and tech with new software platform Joao Andrade and Alan Greenberg of WideCells Group PLC (LON:WDC) discuss with Proactive their plans to develop a software platform that both educates and keeps medical professionals and parents up to date on new treatments and developments.

A commercial launch is targeted for the first quarter of next year.

Annual membership will start at £120 per doctor/medical professional, while sponsors will be able to gain access to the Premium Platform.

Mon, 25 Sep 2017 12:54:00 +0100
OptiBiotix 'gaining real commercial traction' - CEO Stephen O'Hara Stephen O'Hara, chief executive of OptiBiotix Health plc (LON:OPTI), tells Proactive they're to launch an improved version of their weight loss product Slimbiome at a major US trade fair at the end of the month.

Optibiotix already has US product registration for Slimbiome, which is a patented combination of natural ingredients, and will launch the new version at the Supply Side West trade show where it will be exhibited with Cereal Ingredients Inc, a potential joint development partner.

In a wide-ranging discussion O'Hara also brought Proactive up to speed on developments with LPLDL - another of their innovations that is gaining market traction.

OptiBiotix struck a profit-sharing deal with Italian firm Sacco to manufacture and supply the cholesterol-reducing compound and the first sales of the product were made to HLH BioPharma Vertriebs.

Tue, 19 Sep 2017 15:36:00 +0100
Optibiotix signs 'very good' manufacturing deal with Tata Chemicals Stephen O'Hara, chief executive of OptiBiotix Health plc (LON:OPTI) tells Proactive's Andrew Scott they've signed a manufacturing agreement with India-listed food ingredients giant Tata Chemicals.

It is an expansion of a deal the two inked last December and gives Tata, part of the Tata Group, the exclusive rights to produce a sugar from OptiBiotix’s LP-LDL probiotic strain.

Tue, 05 Sep 2017 14:17:00 +0100
Does US court ruling spell the end for Indivior? Proactive Investors editor Ian Lyall discusses the patent infringement case that effectively gives the green light to a company called Dr Reddy’s to produce a copycat version of Indivior PLC's (LON:INDV) heroin subsitute drug Suboxone at a fraction of the current price.

The immediate reaction on the markets was one of horror as 40%, or £1.1bn was wiped from Indivior’s value.

Fri, 01 Sep 2017 16:20:00 +0100
Optibiotix broadens tie-up with Sacco to cover US and rest of the world Stephen O'Hara, chief executive of OptiBiotix Health plc (LON:OPTI) tells Proactive they're extending a key manufacturing and supply agreement.

They're broadening their European tie-up with Italian food company Sacco, signed in March, to cover the US and rest of the world.

Tue, 22 Aug 2017 12:20:00 +0100
Akers Bio sees 'material commercial growth' for Heparin allergy test Akers Biosciences Inc (LON:AKR, NASDAQ:AKER) chief executive John Gormally and vice chairman and co-founder Ray Akers discuss with Proactive's Andrew Scott the firm's first half progress.

The heparin breath test is the company's lead product; however the company’s OxiChek device for oxidative stress is also gaining traction.

As well as the PIFA Heparin and OxiChek lines, the company has developed BreathScan Lync, a new blue-tooth enabled device that allows users to track results from its OxiChek product via smartphone.

They're also currently manufacturing an initial order for First Check Diagnostics, which is the sole US distributor for a rapid cholesterol self-test.

Wed, 16 Aug 2017 14:17:00 +0100
WideCells supercharged to support growth plans Joao Andrade, chief executive of WideCells Group PLC (LON:WDC), talks Proactive through their £750,000 fundraise as the regenerative medicines specialist looks to further its penetration of the rapidly growing stem cell market.

Wed, 16 Aug 2017 12:26:00 +0100
Milestone for Optibiotix with first sales in Germany of LPLDL capsules Stephen O'Hara, chief executive of OptiBiotix Health plc (LON:OPTI) tells Proactive they've reached a significant milestone with first sales in Germany of a new range of cholesterol-lowering capsules containing their breakthrough LP-LDL technology.

Wed, 26 Jul 2017 12:39:00 +0100
Launch of synthetic bone graft opens up 'exciting' new market and opportunities for WideCells WideCells Group PLC (LON:WIDE) Chief executive Joao Andrade and Chief Scientific Officer Peter Hollands chat through the launch of a new synthetic bone graft in the UK that will be used initially in tooth fillings.

Andrade also discusses the recent launch of the Cellplan e-commerce platform in the UK.

Tue, 25 Jul 2017 16:05:00 +0100
Zak Mir expects OptiBiotix to trade in current range for time being OptiBiotix Health plc (LON:OPTI) shares have been trading in a range of between 60p and 85p for the past 18  months, and technical analyst Zak Mir expects that to continue in the short term.

“We can see that there’s been consolidation over the near term, basically in a range of between 60p and 85p,” explains Mir in the latest Proactive Investors Bulletin Board.

“The floor of that range has been in place for the past year and a half and we would expect that to continue for the near term.”

Tue, 11 Jul 2017 10:15:00 +0100
WideCells hails roll out of 'first of its kind' CellPlan in Brazil WideCells Group plc (LON:WDC) CEO Joao Andrade and CFO David Bridgland tell Proactive they've signed a definitive agreement with Brazilian cord blood storage facility, Hemocord Clinica Medica Ltd, to supply its stem cell services.

CellPlan Limited, a wholly-owned subsidiary of Widecells, will offer new and existing clients of Hemocord its stem cell healthcare insurance plan and medical concierge service.

Tue, 04 Jul 2017 08:51:00 +0100
Widecells' Joao Andrade 'very proud' to have Cellplan now available in the UK João Andrade, chief executive of WideCells Group PLC (LON:WDC) tells Proactive their stem cell healthcare insurance, CellPlan, is now available to customers of Biovault, the country’s largest private human tissue storage facility.

Wed, 28 Jun 2017 15:43:00 +0100